CytoDyn Files Form S-3 to Replace Expiring Shelf
VANCOUVER, Wash., March 03, 2021 (GLOBE NEWSWIRE) - CytoDyn Inc. (OTC.QB: CYDY), ("CytoDyn" or the "Firm"), a late-stage biotechnology firm creating Vyrologix ™ (Leronlimab-PRO 140), a CCR5 antagonist with potential for a number of…